Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Aviva plc
  6. News
  7. Summary
    AV.   GB0002162385


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Aviva falls on Friends Life merger plan doubts

11/24/2014 | 09:57am EDT
A man walks past an AVIVA logo outside the company's head office in the city of London

LONDON (Reuters) - Shares in insurer Aviva (>> Aviva plc) fell more than five percent on Monday reflecting uncertainty about the potential benefits of the company's 5.6 billion pound (8.79 billion US dollar) plan to merge with rival Friends Life (>> Friends Life Group Ltd)

LONDON (Reuters) - Shares in insurer Aviva (>> Aviva plc) fell more than five percent on Monday reflecting uncertainty about the potential benefits of the company's 5.6 billion pound (8.79 billion US dollar) plan to merge with rival Friends Life (>> Friends Life Group Ltd)

The two insurers have agreed outline terms for a possible all-share deal, in which Aviva would offer a 15 percent premium to Friends Life's share price to give those investors a 26 percent stake in the new company.

The proposed transaction, first announced on Friday, would create a market leader in British life insurance with a combined market capitalisation of about 20.2 billion pounds.

The deal aims to bolster the balance sheet of Aviva, helped by Friends Life's strong cash generation, as well as boosting assets under management and cutting costs.

Shares in Friends Life (>> Friends Life Group Ltd) rose as much as 8.2 percent. They were about 4.2 percent higher by 1425 GMT

Investors and analysts see the plan as a move towards much-needed consolidation in Britain's insurance industry given big pension changes that will give people more say over how they invest their retirement savings.

"The initial assessment suggests the valuation for the deal is fair," said Alessandro Valentini, fund manager at Causeway Capital, which owns Aviva shares.

But Aviva and Friends Life have not yet given figures on cost savings or other benefits from their merger plan.

Potential savings could come from rationalising management and staffing and closing Friends Life head office, analysts at Societe Generale said.

The proposed deal marks a significant step for Aviva boss Mark Wilson, who was hired as CEO of general and life insurer Aviva from Asian rival AIA (>> AIA Group Ltd) two years ago.

He has pushed through a restructuring, selling off businesses, cutting costs and improving profitability. Investors said Wilson had met with them at the weekend to discuss the deal.

Analysts at Bernstein estimated the merger should produce cost and revenue benefits of 1.7 billion pounds, more than offsetting the offer premium which they put at 700 million pounds.

The valuation for the combined company did not look expensive, with UBS analysts putting the 2015 price to earnings multiple at 11.3 times, compared with 10.1 times for Aviva currently. British insurers are trading at 12.6 times on average, according to Thomson Reuters StarMine data.

Eamonn Flanagan, analyst at Shore Capital, reiterated his "sell" recommendation on Aviva, saying the merger was a rights issue in disguise.

Flanagan said the plan raised concerns over the pace of progress within the Aviva's restructuring and turnaround, both in terms of cash generation and reducing debt. "The key question for us is why Aviva felt the need to do this deal now?"

The proposal has the backing of entrepreneur Clive Cowdery, who founded Friends Life in 2008 when it was known as Resolution. The company began buying up closed books of life insurance business and using its scale to make cost savings in managing them.

Cowdery stepped down this year but is still the 15th largest shareholder in Friends Life, according to Thomson Reuters data.

Most analysts did not expect a rival bid, with Canaccord Genuity putting the chances at below 20 percent, due to a lack of likely contenders.

(Additional reporting by Simon Jessop and Nishant Kumar; editing by Steve Slater and Jane Merriman)

By Carolyn Cohn

Stocks treated in this article : Aviva plc, Friends Life Group Ltd, AIA Group Ltd

ę Reuters 2014
Stocks mentioned in the article
ChangeLast1st jan.
AIA GROUP LIMITED -3.88% 89.25 End-of-day quote.-6.05%
AVIVA PLC -1.10% 386 Delayed Quote.20.02%
All news about AVIVA PLC
08:40aWELLBEING SPECIAL : tips to tackle 'lockdown anxiety'
07/23AVIVA : Exane BNP Downgrades Aviva To Underperform
07/23ANALYST RECOMMENDATIONS : Apple, Aviva, Biogen, Comerica Incorporated, Tesla...
07/23Consumer staples, miners lift London's FTSE 100; Vodafone surges
07/22AVIVA : announces ú900m bulk annuity deal with Kingfisher Pension Scheme
07/21AVIVA : Natural disaster H1 insured losses hit 10-year high-Aon
07/21Irish insurance regulator urges reform of renewal rules
07/21AVIVA : Morgan Stanley Lowers Aviva to Equalweight from Overweight
07/21AVIVA : Seven steps to help protect UK homes, businesses and communities from cl..
07/20AVIVA : British homes, businesses unprepared for climate change, Aviva says
More news
Sales 2021 46 772 M 64 915 M 64 915 M
Net income 2021 2 260 M 3 136 M 3 136 M
Net cash 2021 8 664 M 12 025 M 12 025 M
P/E ratio 2021 6,83x
Yield 2021 5,69%
Capitalization 15 161 M 20 955 M 21 043 M
EV / Sales 2021 0,14x
EV / Sales 2022 0,14x
Nbr of Employees 28 596
Free-Float 97,1%
Duration : Period :
Aviva plc Technical Analysis Chart | AV. | GB0002162385 | MarketScreener
Technical analysis trends AVIVA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 3,86 GBX
Average target price 466,10 GBX
Spread / Average Target 11 975%
EPS Revisions
Managers and Directors
Amanda Blanc Chief Executive Officer & Executive Director
Jason Michael Windsor Chief Financial Officer & Director
Mark George Culmer Non-Executive Chairman
Nitinbhai Babubhai Maganbhai Amin Chief Operating Officer
Michael Mire Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
AVIVA PLC20.02%21 188
AXA12.24%61 729
METLIFE, INC.23.64%50 818